某三甲医院2012-2014年麻醉药品和第一类精神药品使用分析

发布时间：2018-11-01 14:58

【摘要】：目的:为晚期癌症、中重度疼痛镇痛药物的合理使用提供参考。方法:从某三甲医院的信息管理系统中提取2012-2014年麻醉药品和第一类精神药品的相关数据,对使用数量和销售金额、用药频度(DDDs)等进行统计分析。结果:该院2012-2014年麻醉药品和第一类精神药品的整体使用数量基本持平,各年的销售金额分别为1 566 289.92、1 525 220.23、1 531 277.44元。盐酸吗啡片的销售金额增长最快,2013、2014年分别比前一年增长了89.78%和142.81%,其余药品大多为负增长。盐酸吗啡缓释片的DDDs 3年均排名第1且逐年递增,从2012年的26 848.00增加至2014年的47 158.00。结论:该院麻醉药品和第一类精神药品用药基本符合规范,但仍然需要严格监管,使之更加安全、有效地应用于临床。
[Abstract]:Objective: to provide reference for the rational use of analgesic drugs for advanced cancer and moderate and severe pain. Methods: the data of narcotic drugs and class I psychotropic drugs were extracted from the information management system of a third Class A Hospital from 2012 to 2014. The quantity of use, the amount of money sold, the frequency of drug use and (DDDs) were statistically analyzed. Results: from 2012 to 2014, the total use of narcotic drugs and the first kind of psychotropic drugs in our hospital was basically the same, and the sales amount in each year was 1 566,289.92 / 1 525 220.2331,531 277.44 yuan respectively. Sales of morphine hydrochloride tablets grew the fastest, up 89.78 percent in 2013 and 142.81 in 2014 compared with the previous year, while the rest were mostly negative. Morphine hydrochloride sustained-release tablets ranked first in annual DDDs 3 and increased year by year, from 26 848.00 in 2012 to 47,158.00 in 2014. Conclusion: the drug use of narcotic drugs and psychotropic drugs in this hospital basically conforms to the standard, but it still needs strict supervision to make it more safe and effective in clinical application.
【作者单位】：四川大学华西公共卫生学院/华西第四医院;
【分类号】：R95

【参考文献】